Grand Pharmaceutical GroupCGPHF 86 PS Ratio is 0.00 as of Jul. 06, 2026. GuruFocus rates CGPHF with a GF Score™ of 86/100. The stock has 6 warning signs investors should review. Among 952 Drug Manufacturers companies, Grand Pharmaceutical Group ranks better than 63.66% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Grand Pharmaceutical Group's share price is $0.00.
Grand Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.45. Hence, Grand Pharmaceutical Group's PS Ratio for today is 0.00.
The historical rank and industry rank for Grand Pharmaceutical Group's PS Ratio or its related term are showing as below:
CGPHF'
s PS Ratio Range Over the Past 10 Years
Min: 0.92 Med: 1.97 Max: 4.34
Current: 1.47
During the past 13 years, Grand Pharmaceutical Group's highest PS Ratio was 4.34. The lowest was 0.92. And the median was 1.97.
CGPHF's PS Ratio is ranked better than 63.66% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs CGPHF: 1.47
Grand Pharmaceutical Group Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Grand Pharmaceutical Group was 5.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 9.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.90% per year.
During the past 13 years, Grand Pharmaceutical Group's highest 3-Year average Revenue per Share Growth Rate was 152.70% per year. The lowest was -47.50% per year. And the median was 11.60% per year.
Back to Basics: PS Ratio
Grand Pharmaceutical Group (OTCPK:CGPHF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Grand Pharmaceutical Group PS Ratio Related Terms
Grand Pharmaceutical Group PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Pharmaceutical Group PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Grand Pharmaceutical Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Grand Pharmaceutical Group's Share Price of today is $0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Grand Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.45.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Grand Pharmaceutical Group (CGPHF) has a PS Ratio of 0.00 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Grand Pharmaceutical Group and its competitors. Over the past decade, Grand Pharmaceutical Group's PS Ratio has ranged from 0.92 to 4.34. According to the industry distribution chart, Grand Pharmaceutical Group ranks #346 out of 952 companies in the Drug Manufacturers industry, placing it in the top 36.3%.
Is Grand Pharmaceutical Group's PS Ratio too high?
Grand Pharmaceutical Group's current PS Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 4.34. Based on the distribution chart, Grand Pharmaceutical Group ranks #346 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Grand Pharmaceutical Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #346 out of 952 companies for PS Ratio. This puts Grand Pharmaceutical Group in the upper half of its industry. The industry median PS Ratio is 2.32. Historically, Grand Pharmaceutical Group's own PS Ratio has ranged from 0.92 to 4.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Grand Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Pharmaceutical Group's current PS Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current PS Ratio of 0.00. The current PS Ratio is 0.00. Grand Pharmaceutical Group's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current PS Ratio is 0.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGPHF has been successfully added to your 